Bio-Techne (TECH) Interest Coverage Ratio Growth (3y) (2017 - 2026)
Bio-Techne (TECH) Interest Coverage Ratio Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
29.25% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-16.86% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Bio-Techne |
9.04 Bn |
8.83 Bn |
208.29 Mn |
-18.79% |
| Date | Value |
|---|
| Mar 31, 2026 |
-18.79% |
| Dec 31, 2025 |
-4.52% |
| Sep 30, 2025 |
3.01% |
| Jun 30, 2025 |
-32.77% |
| Mar 31, 2025 |
-18.99% |
| Dec 31, 2024 |
0.91% |
| Sep 30, 2024 |
-0.31% |
| Jun 30, 2024 |
-4.30% |
| Mar 31, 2024 |
-13.45% |
| Dec 31, 2023 |
-14.86% |
| Sep 30, 2023 |
0.89% |
| Jun 30, 2023 |
44.21% |
| Mar 31, 2023 |
76.60% |
| Dec 31, 2022 |
55.98% |
| Sep 30, 2022 |
32.54% |
| Jun 30, 2022 |
60.82% |
| Mar 31, 2022 |
61.44% |
| Dec 31, 2021 |
54.42% |
| Sep 30, 2021 |
55.66% |
| Jun 30, 2021 |
63.91% |
